Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.34% | -63.31% | -82.34% | -54.01% | -42.00% |
| Total Depreciation and Amortization | 94.82% | 41.93% | -6.18% | 43.87% | -1.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.42% | 90.18% | 158.76% | 92.02% | 40.48% |
| Change in Net Operating Assets | 40.37% | 34.25% | 36.80% | 18.37% | 1,286.64% |
| Cash from Operations | -16.54% | -11.57% | 28.85% | 9.26% | 20.41% |
| Capital Expenditure | 76.19% | 80.18% | 63.94% | 94.61% | 84.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.19% | 80.18% | 63.94% | 94.61% | 84.73% |
| Total Debt Issued | -39.76% | -30.36% | -2.71% | 30.20% | 29.07% |
| Total Debt Repaid | 75.22% | 54.25% | -25.45% | -76.76% | -75.79% |
| Issuance of Common Stock | -100.00% | -77.63% | 445.05% | 1,371.84% | 1,371.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.81% | 2.45% | -25.16% | -7.90% | -25.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.81% | -296.01% | 160.36% | 47.89% | -228.67% |